advertisement
Xia X 13
Showing records 1 to 13 |
Display all abstracts from Xia X123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptideZhu Y
Experimental Eye Research 2024; 246: 110017
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma TreatmentsZhou X
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptideNair RV
Experimental Eye Research 2024; 246: 110017
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma TreatmentsRong R; Liang G
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptideXia X
Experimental Eye Research 2024; 246: 110017
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma TreatmentsWu Y
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptideNahmou M
Experimental Eye Research 2024; 246: 110017
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma TreatmentsXu C
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptideLi X; Yan W
Experimental Eye Research 2024; 246: 110017
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma TreatmentsXiao H
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptideLi J
Experimental Eye Research 2024; 246: 110017
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma TreatmentsJi D; Xia X
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptideTanasa B; Goldberg JL; Kapiloff MS
Experimental Eye Research 2024; 246: 110017